Direct accesses

  • Go to main menu
  • Go to main content
Menu
GenSight GenSight
Search the site
  • Contact
  • Careers
  • You are viewing the website in English en
  • fr
Search the site
  • Whowe are
    • Company
    • Leadership
    • Collaborations
  • Diseaseswe target
    • Diseases we target
    • Leber Hereditary Optic Neuropathy (LHON)
    • Retinitis Pigmentosa (RP)
    • Geographic Atrophy in Dry-AMD
  • Ourtechnologies
    • Technologies we are applying
    • Gene Therapy
    • Mitochondrial Targeting Sequence (MTS)
    • Optogenetics
    • Clinical development Summary
  • Investors
    • Company Overview
    • Financial press releases
    • Investor Newsletters
    • Events & presentations
    • Stock information & Financial agenda
    • Governance
    • Documentation
  • Media

Documentation

  • Home >
  • Investors & media >
  • Documentation
23 April 2025
General Assembly, General meetings

Rapport des commissaires aux comptes sur les états financiers annuels 2024 en normes françaises Open in new window

23 April 2025
General Assembly, General meetings

AGM 2025 – Board nominees Open in new window

23 April 2025
General Assembly, General meetings

Report on capital reduction Open in new window

23 April 2025
General Assembly, General meetings

2025 AGM – Notice and Convening Brochure Open in new window

23 April 2025
General Assembly, General meetings

Global delegation report Open in new window

23 April 2025
General Assembly, General meetings

Preliminary Notice of the General Meeting 2025 Open in new window

23 April 2025
General Assembly, General meetings

Report on CAPITAL INCREASE RESERVED FOR EMPLOYEES Open in new window

23 April 2025
General Assembly, General meetings

Free shares Report Open in new window

23 April 2025
General Assembly, General meetings

Stock Option Report Open in new window

23 April 2025
General Assembly, General meetings

OCA Report Open in new window

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 23
  • View next 9 articles
© 2025 Gensight Biologics
  • Terms of use
  • Sitemap
  • Contact
  • Credits
  • Cookies management
Go back to the page of the page